Tanvex BioPharma Inc (6541) — Financial Flexibility Index
Tanvex BioPharma Inc (6541) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of NT$-133.84 Million (operating CF NT$-309.37 Million minus capex NT$175.53 Million) represents 0% of total liabilities (NT$2.27 Billion). Check strategic asset allocation of Tanvex BioPharma Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tanvex BioPharma Inc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Tanvex BioPharma Inc across 13 annual periods. See working capital position of Tanvex BioPharma Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tanvex BioPharma Inc (2013–2025)
Year-by-year free cash flow to debt coverage for Tanvex BioPharma Inc. For the full company profile including market capitalisation, see market cap of Tanvex BioPharma Inc.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.15x | NT$-335.24 Million | NT$-1.01 Billion | NT$2.27 Billion | ▲ +73.8% |
| 2024 | -0.56x | NT$-1.04 Billion | NT$-1.15 Billion | NT$1.84 Billion | ▲ +19.5% |
| 2023 | -0.70x | NT$-1.36 Billion | NT$-1.43 Billion | NT$1.94 Billion | ▼ -15.0% |
| 2022 | -0.61x | NT$-1.24 Billion | NT$-1.33 Billion | NT$2.03 Billion | ▲ +13.7% |
| 2021 | -0.71x | NT$-1.36 Billion | NT$-1.39 Billion | NT$1.92 Billion | ▲ +28.0% |
| 2020 | -0.98x | NT$-1.72 Billion | NT$-1.79 Billion | NT$1.75 Billion | ▲ +70.5% |
| 2019 | -3.33x | NT$-1.81 Billion | NT$-1.90 Billion | NT$542.12 Million | ▲ +41.3% |
| 2018 | -5.67x | NT$-1.50 Billion | NT$-1.61 Billion | NT$263.92 Million | ▼ -15.9% |
| 2017 | -4.90x | NT$-1.10 Billion | NT$-1.21 Billion | NT$223.78 Million | ▼ -150.5% |
| 2016 | -1.95x | NT$-584.86 Million | NT$-833.43 Million | NT$299.25 Million | ▲ +23.6% |
| 2015 | -2.56x | NT$-310.73 Million | NT$-684.20 Million | NT$121.41 Million | ▲ +40.1% |
| 2014 | -4.27x | NT$-278.11 Million | NT$-434.17 Million | NT$65.09 Million | ▼ -85.7% |
| 2013 | -2.30x | NT$-192.38 Million | NT$-239.86 Million | NT$83.63 Million | — |